Byrne Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
Byrne Asset Management's LLY Position: Q2 2026 in Review
Byrne Asset Management increased its Eli Lilly (LLY) stake by 18% in Q2 2026, buying an estimated $78.7K and bringing the position to 517 shares worth $620K. The position accounts for 0.34% of the portfolio, ranked #72.
Byrne Asset Management first reported a position in LLY in Q4 2021 and has held it in 17 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Byrne Asset Management held 517 shares of Eli Lilly worth $620K as of Q2 2026.
- Byrne Asset Management bought 77 Eli Lilly shares in Q2 2026, an estimated $78.7K.
- Eli Lilly made up 0.34% of Byrne Asset Management's portfolio in Q2 2026, its #72 holding.
- Byrne Asset Management first reported a position in Eli Lilly in Q4 2021 and has held it in 17 quarters since.
- 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.